ZDHHC9: a promising therapeutic target for triple-negative breast cancer through immune modulation and immune checkpoint blockade resistance

ZDHHC9: a promising therapeutic target for triple-negative breast cancer through immune modulation and immune checkpoint blockade resistance

Abstract Background Triple-negative breast cancer (TNBC) is a subtype of breast cancer with limited treatment options and poor prognosis. This study aimed to identify potential therapeutic targets based on the expression profiles of differentially expressed genes (DEGs) in TNBC. Methods The Limma pa...

Full description

Bibliographic Details
Main Authors: Chao Xu, Yongjie Xie, Peng Xie, Jianming Li, Zhongsheng Tong, Yanfang Yang
Format: Article
Language:English
Published: Springer 2023-10-01
Series:Discover Oncology
Subjects:
TNBC
ZDHHC9
Immune biomarkers
Immunotherapy resistance
Online Access:https://doi.org/10.1007/s12672-023-00790-4

Internet

https://doi.org/10.1007/s12672-023-00790-4

Similar Items